Back to top
more

Defiance Daily Target 2x Long LMND ETF: (LMNX)

(Delayed Data from NASDAQ) As of Feb 24, 2026 04:00 PM ET

$13.27 USD

13.27
196,171

+0.47 (3.67%)

Volume: 196,171

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $14.00 +0.73 (5.50 %) 7:58 PM ET

Zacks News

Zacks Equity Research

Luminex (LMNX) Q4 Earnings Miss Estimates, Revenues Beat

Luminex (LMNX) witnesses total sample-to-answer molecular diagnostics revenue growth in the fourth quarter.

Zacks Equity Research

Luminex (LMNX) Q4 Earnings Miss Estimates

Luminex (LMNX) delivered earnings and revenue surprises of -92.86% and 0.35%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Why Is Luminex (LMNX) Down 0.8% Since Last Earnings Report?

Luminex (LMNX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Luminex (LMNX) Declines 6.6% as Q3 Earnings Miss Estimates

Luminex (LMNX) witnessed total sample-to-answer molecular diagnostics revenue growth in the third quarter.

Zacks Equity Research

Luminex (LMNX) Earnings Expected to Grow: Should You Buy?

Luminex (LMNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Here's Why You Should Retain Luminex (LMNX) Stock for Now

Investor confidence is high on Luminex (LMNX) stock, thanks to solid prospects.

Zacks Equity Research

Luminex (LMNX) Down 34.6% Since Last Earnings Report: Can It Rebound?

Luminex (LMNX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Here's Why You Should Retain Luminex (LMNX) Stock for Now

Investor confidence is high on Luminex (LMNX) stock, thanks to solid prospects.

Zacks Equity Research

Luminex (LMNX) Q2 Earnings Beat Estimates, Revenues Miss

Luminex (LMNX) witnessed total sample-to-answer molecular diagnostics revenue growth in Q2

Zacks Equity Research

Luminex (LMNX) Q2 Earnings Surpass Estimates

Luminex (LMNX) delivered earnings and revenue surprises of 237.50% and -0.07%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?